A previous study suggested that targeting BRD4 may confer a clinical benefit in proliferation of cancer cells via the increase in ferritinophagy and enhanced the ferroptosis31, suppression of BRD4 may be associated with the pathogenesis of PD. Here, BRD4 is linked to Parkinson disease.